The Thymosin a1 Market in China 2018-2022 - By Sales, Patheon Captured More Than Half of the Market in 2017 - ResearchAndMarkets.com

DUBLIN--()--The "Investigation Report on Chinese Thymosin a1 Market, 2018-2022" report has been added to ResearchAndMarkets.com's offering.

According to the report, Thymosin 1 has been growing since it entered China, with its sales value increasing from less than CNY 7 million in 2015 to more than CNY 1.2 billion in 2017.

The Chinese Thymosin 1 market is now dominated by the products of Patheon, Hainan Shuangcheng Pharmaceuticals Co., Ltd., Chengdu DIAO Jiuhong Pharmaceutical Factory, etc.

By sales value, Patheon captured more than half of the market, becoming the most powerful market player in 2017. By sales volume, Chengdu DIAO Jiuhong Pharmaceutical Factory took up the largest market share. Many domestic enterprises seek to scrabble for market shares from Patheon by the advantage of low prices.

According to research, the incidence of cancer is increasing with economic development, aggravating environmental pollution and residents' changing lifestyle; therefore, the Thymosin 1 market will continue to grow from 2018 to 2022 as the immunomodulator market grows gradually.

Companies Mentioned

  • Patheon N.V.
  • Chengdu DIAO Jiuhong Pharmaceutical Factory
  • Hainan Shuangcheng Pharmaceuticals
  • Hainan Zhonghe Pharmaceutical
  • SPH No. 1 Biochemical & Pharmaceutical
  • Suzhou Tianma Pharma Group Tianji Bio-Pharmaceutical
  • Chengdu Shengnuo Biopharm
  • Harbin Pharmaceutical Group Bio-Engineering

Topics Covered

  • Size of Chinese Thymosin 1 market
  • Competition pattern of the Chinese Thymosin 1 market

Key Topics Covered

1 Relevant Concepts of Thymosin 1

2 Investigation on Sales of Thymosin 1 in China, 2013-2017

3 Market Shares of Major Thymosin 1 Manufacturers in China

4 Prices of Thymosin 1 in China, 2017-2018

5 Prospects of Chinese Thymosin 1 arket, 2018-2022

For more information about this report visit https://www.researchandmarkets.com/research/xn3j9x/the_thymosin_a1?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Oncology Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Oncology Drugs